Correlation Between Eli Lilly and Eyenovia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Eyenovia, you can compare the effects of market volatilities on Eli Lilly and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Eyenovia.

Diversification Opportunities for Eli Lilly and Eyenovia

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Eli and Eyenovia is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Eli Lilly i.e., Eli Lilly and Eyenovia go up and down completely randomly.

Pair Corralation between Eli Lilly and Eyenovia

Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.14 times more return on investment than Eyenovia. However, Eli Lilly and is 6.99 times less risky than Eyenovia. It trades about -0.21 of its potential returns per unit of risk. Eyenovia is currently generating about -0.26 per unit of risk. If you would invest  90,209  in Eli Lilly and on August 30, 2024 and sell it today you would lose (11,390) from holding Eli Lilly and or give up 12.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  Eyenovia

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Eli Lilly and Eyenovia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Eyenovia

The main advantage of trading using opposite Eli Lilly and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.
The idea behind Eli Lilly and and Eyenovia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum